Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Sundy

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Rheumatology Reports|March 20, 2001
COX-2 inhibitors in rheumatoid arthritisJ S Sundy
Current Rheumatology Reports|December 21, 2000
Cytokines and adhesion molecules in the pathogenesis of vasculitisJ S Sundy, B F Haynes
Drugs of Today (Barcelona, Spain : 1998)|July 31, 2012
Pegloticase for treating refractory chronic goutR L George, J S Sundy
Rheumatic Diseases Clinics of North America|November 1, 1995
Pathogenic mechanisms of vessel damage in vasculitis syndromesJ S Sundy, B F Haynes
Arthritis and Rheumatism|January 1, 1996
Rocky Mountain spotted fever presenting with acute monarticular arthritisJ S Sundy, N B Allen, D J Sexton
Journal of Medical Economics|December 9, 2010
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapyN L Edwards, J S Sundy, A Forsythe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1989
Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparumD M Russo, J S Sundy, J F Young, et al.
Annals of the Rheumatic Diseases|July 29, 2009
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot studyR Terkeltaub, J S Sundy, H R Schumacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Immunologic characterization of CD7-deficient miceD M Lee, H F Staats, J S Sundy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophyG D Sempowski, L P Hale, J S Sundy, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Rheumatology Reports|March 20, 2001
COX-2 inhibitors in rheumatoid arthritisJ S Sundy
Current Rheumatology Reports|December 21, 2000
Cytokines and adhesion molecules in the pathogenesis of vasculitisJ S Sundy, B F Haynes
Drugs of Today (Barcelona, Spain : 1998)|July 31, 2012
Pegloticase for treating refractory chronic goutR L George, J S Sundy
Rheumatic Diseases Clinics of North America|November 1, 1995
Pathogenic mechanisms of vessel damage in vasculitis syndromesJ S Sundy, B F Haynes
Arthritis and Rheumatism|January 1, 1996
Rocky Mountain spotted fever presenting with acute monarticular arthritisJ S Sundy, N B Allen, D J Sexton
Journal of Medical Economics|December 9, 2010
Work productivity loss due to flares in patients with chronic gout refractory to conventional therapyN L Edwards, J S Sundy, A Forsythe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1989
Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparumD M Russo, J S Sundy, J F Young, et al.
Annals of the Rheumatic Diseases|July 29, 2009
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot studyR Terkeltaub, J S Sundy, H R Schumacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Immunologic characterization of CD7-deficient miceD M Lee, H F Staats, J S Sundy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophyG D Sempowski, L P Hale, J S Sundy, et al.
Pageof 2